|
|
???tair.name??? >
???browser.page.title.author???
|
"chun jen liu"???jsp.browse.items-by-author.description???
Showing items 476-500 of 543 (22 Page(s) Totally)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection
|
Liu, Chun-Jen;Chen, Pei-Jer;Lai, Ming-Yang;Liu, Chen-Hua;Chen, Chi-Ling;Kao, Jia-Horng;Chen, Ding-Shinn; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHEN, PEI-JER; LAI, MING-YANG; LIU, CHEN-HUA; CHEN, CHI-LING; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 臺大學術典藏 |
2018-09-10T07:11:03Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou, Y.-C.;Yu, M.-W.;Wu, C.-F.;Yang, S.-Y.;Lin, C.-L.;Liu, C.-J.;Shin, W.-L.;Chen, P.-J.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU; Chou, YC; CHUN-JEN LIU; Yu, MW; Wu, CF; Yang, SY; Lin, CL; Liu, CJ; Shih, WL; Chen, PJ; Liaw, YF; Chen, CJ. |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations
|
Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:33Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu, C.-S.;Liu, C.-J.;Liu, C.-H.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:33:21Z |
Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; Tseng, TC; CHUN-JEN LIU; Liu, CJ; JIA-HORNG KAO; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T06:33:20Z |
Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges
|
Liu, C.-H. and Liu, C.-J. and Kao, J.-H.; CHUN-JEN LIU; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:33:18Z |
Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients
|
Wang, C.-C.;Liu, C.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lai, My; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users
|
PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; Lai, MY; JIA-HORNG KAO; Chen, DS; Kao, JH.; Lin, C.-.;Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; Lin, CL; Liu, CJ |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan
|
Tseng, T.-C.; Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Lin, C.-L.; Kao, J.-K.; Chen, D.-S.; CHUN-JEN LIU; Tseng, TC; Liu, CJ; PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; JIA-HORNG KAO; Lai, MY; Lin, CL; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan
|
Shao, Yu-Yun; Liu, CJ; PEI-JER CHEN; Lai, MY; DING-SHINN CHEN; Lee, Yi-Hsuan; Hsieh, Min-Shu; JIA-HORNG KAO; Chen, PJ; Kao, JH; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Chen, DS.; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒; Hsu, CS; Hsu, C.-S.; Liu, C.-J.; Lai, M.-Y.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; Lu, Li-Chun; CHUN-JEN LIU |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels
|
Lin, Chih-Lin; Liao, Li-Ying; Liu, Chun-Jen; Yu, Ming-Whei; Chen, Pei-Jer; Lai, Ming-Yang; Chen, Ding-Shinn; Kao, Jia-Horng; Lin, Chih-Lin; MING-WHEI YU; Lin, CL; Liao, LY; Liao, Li-Ying; CHUN-JEN LIU; Liu, CJ; PEI-JER CHEN; Liu, Chun-Jen; Kao, Jia-Horng; Kao, JH.; Chen, Ding-Shinn; Chen, DS; Lai, Ming-Yang; Lai, MY; Chen, Pei-Jer; Chen, PJ; JIA-HORNG KAO; DING-SHINN CHEN; Yu, MW; Yu, Ming-Whei |
| 臺大學術典藏 |
2018-09-10T06:14:05Z |
Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index.
|
Hsu, SJ; CHUN-JEN LIU; Chang, Chi-Yang; Lin, JW; PEI-JER CHEN; CHEN-HUA LIU; Hwang, JJ; Liu, CJ; PEI-MING YANG; DING-SHINN CHEN; Yang, PM; Lai, MY; JIA-HORNG KAO; Chen, PJ; Chen, JH; Kao, JH; Chen, DS.; Liu, CH; JUEY-JEN HWANG; Chang, Chi-Yang;Kao, JH;Lai, MY;Chen, DS.;Yang, PM;Hwang, JJ;Lin, JW;Hsu, SJ;Liu, CJ;Liu, CH;Chen, JH;Chen, PJ;JUEY-JEN HWANG;CHUN-JEN LIU;PEI-JER CHEN;CHEN-HUA LIU;PEI-MING YANG;DING-SHINN CHEN;JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:12:48Z |
Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma
|
Lin, C.-L.;Chen, J.-D.;Liu, C.-J.;Lee, P.-H.;Chen, P.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Lin, CL; PO-HUANG LEE; CHUN-JEN LIU; Chen, JD; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lee, PH; Chen, PJ; Lai, MY; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:06:19Z |
Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan
|
JIA-HORNG KAO; SHIOU-HWEI YEH; Liu, C.-J. and Lo, S.-C. and Kao, J.-H. and Tseng, P.-T. and Lai, M.-Y. and Ni, Y.-H. and Yeh, S.-H. and Chen, P.-J. and Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; SHYH-CHYI LO; Yen-Hsuan Ni; DING-SHINN CHEN |
| 臺大學術典藏 |
2018-09-10T06:00:49Z |
Pegylated interferons for the treatment of chronic hepatitis B.
|
Liu, C.J.;Kao, J.H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:48Z |
Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants
|
Liu, C.-J.;Kao, J.-H.;Chen, P.-J.;Chen, T.-C.;Lin, F.-Y.;Lai, M.-Y.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:47Z |
Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study
|
Liu, C.-J.;Lai, M.-Y.;Chao, Y.-C.;Liao, L.-Y.;Yang, S.-S.;Hsiao, T.-J.;Hsieh, T.-Y.;Lin, C.-L.;Hu, J.-T.;Chen, C.-L.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
Showing items 476-500 of 543 (22 Page(s) Totally)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
View [10|25|50] records per page
|
